Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:00 pm Sale | 2026-03-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | Perceptive Advisors LLC | 3,519,626 5.100% | -903,815 (-20.43%) | Filing History |
| 2026-04-30 12:56 pm Purchase | 2026-03-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | VANGUARD CAPITAL MANAGEMENT LLC | 3,432,949 5.020% | 3,432,949 (New Position) | Filing History |
| 2026-03-27 11:33 am Sale | 2026-03-13 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | VANGUARD GROUP INC | 0 0.000% | -6,210,916 (Position Closed) | Filing History |
| 2026-02-17 4:41 pm Purchase | 2025-12-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | RA CAPITAL MANAGEMENT L.P. | 6,666,837 9.900% | 1,105,478 (+19.88%) | Filing History |
| 2026-02-12 10:08 am Sale | 2025-12-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | PRIMECAP MANAGEMENT CO/CA/ | 3,478,669 5.210% | -784,190 (-18.40%) | Filing History |
| 2026-01-30 2:43 pm Purchase | 2025-12-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | VANGUARD GROUP INC | 6,210,916 9.300% | 1,214,489 (+24.31%) | Filing History |
| 2025-11-14 12:14 pm Sale | 2025-09-30 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | PRIMECAP MANAGEMENT CO/CA/ | 4,262,859 6.420% | -615,178 (-12.61%) | Filing History |
| 2025-10-30 3:50 pm Purchase | 2025-09-30 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | VANGUARD GROUP INC | 4,996,427 7.520% | 1,769,489 (+54.83%) | Filing History |
| 2025-08-14 6:04 pm Sale | 2025-06-30 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | RA CAPITAL MANAGEMENT L.P. | 5,561,359 8.700% | -523,053 (-8.60%) | Filing History |
| 2025-08-14 1:28 pm Sale | 2025-06-30 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | PRIMECAP MANAGEMENT CO/CA/ | 4,878,037 7.670% | -909,285 (-15.71%) | Filing History |
| 2025-05-15 6:20 pm Sale | 2025-03-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | Perceptive Advisors LLC | 4,423,441 6.800% | -1,011,769 (-18.62%) | Filing History |
| 2025-05-15 4:19 pm Sale | 2025-03-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | BAKER BROS. ADVISORS LP | 5,604,483 8.900% | -793,882 (-12.41%) | Filing History |
| 2025-05-13 4:27 pm Sale | 2025-03-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | PRIMECAP MANAGEMENT CO/CA/ | 5,787,322 9.150% | -783,868 (-11.93%) | Filing History |
| 2025-04-24 08:59 am Sale | 2025-03-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | BlackRock, Inc. BLK | 4,364,700 6.900% | -1,987,050 (-31.28%) | Filing History |
| 2025-02-13 6:36 pm Sale | 2024-12-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | PRIMECAP MANAGEMENT CO/CA/ | 6,571,190 10.690% | -645,721 (-8.95%) | Filing History |
| 2025-02-10 5:30 pm Sale | 2024-12-31 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | GOLDMAN SACHS GROUP INC GS | 1,818,932 3.000% | -2,072,088 (-53.25%) | Filing History |
| 2024-11-14 9:50 pm Purchase | 2024-09-30 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | Perceptive Advisors LLC | 5,435,210 8.600% | 291,635 (+5.67%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | RA CAPITAL MANAGEMENT L.P. | 6,084,412 9.950% | 754,000 (+14.15%) | Filing History |
| 2024-11-12 5:23 pm Sale | 2024-09-30 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | GOLDMAN SACHS GROUP INC GS | 3,891,020 6.400% | -1,107,741 (-22.16%) | Filing History |
| 2024-11-12 4:01 pm Sale | 2024-09-30 | 13G | RHYTHM PHARMACEUTICALS INC RYTM | PRIMECAP MANAGEMENT CO/CA/ | 7,216,911 11.810% | -835,737 (-10.38%) | Filing History |